Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Inogen, Inc.

In a report released yesterday, from DZ BANK AG maintained a Buy rating on ING GROEP. The company’s shares closed last Monday at €30.67. In additio...

ING GROEP (0RIC) Gets a Buy from DZ BANK AG

In a report released today, Shrey Srivastava from Citi maintained a Buy rating on ING GROEP, with a price target of €33.00. According to TipRanks, ...

Citi Remains a Buy on ING GROEP (0RIC)

UBS analyst Johan Ekblom maintained a Buy rating on ING GROEP today and set a price target of €33.20. According to TipRanks, Ekblom is ranked #217 ...

UBS Keeps Their Buy Rating on ING GROEP (0RIC)

RBC Capital analyst Anke Reingen maintained a Hold rating on ING GROEP today and set a price target of €28.00. According to TipRanks, Reingen is ra...

RBC Capital Sticks to Its Hold Rating for ING GROEP (0RIC)

In a report released yesterday, Tarik El Mejjad from Bank of America Securities reiterated a Hold rating on ING GROEP, with a price target of €30.5...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	INGN	$6.05	-6.78%	599.11K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	INGN	$6.05	-6.8%	599.11K
3
4
5
6

INGN

INGN

Get Inogen, Inc. Data in Excel

Get Inogen, Inc. Data in Excel